Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 490

1.

Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease.

Scheltens NME, van der Weijden K, Adriaanse SM, van Assema D, Oomen PP, Krudop WA, Lammertsma AA, Barkhof F, Koene T, Teunissen CE, Scheltens P, van der Flier WM, Pijnenburg YAL, Yaqub M, Ossenkoppele R, van Berckel BNM.

Neuroimage Clin. 2018 May 22;19:625-632. doi: 10.1016/j.nicl.2018.05.024. eCollection 2018.

2.

Quantification of [18F]florbetapir: A test-retest tracer kinetic modelling study.

Golla SS, Verfaillie SC, Boellaard R, Adriaanse SM, Zwan MD, Schuit RC, Timmers T, Groot C, Schober P, Scheltens P, van der Flier WM, Windhorst AD, van Berckel BN, Lammertsma AA.

J Cereb Blood Flow Metab. 2018 Jan 1:271678X18783628. doi: 10.1177/0271678X18783628. [Epub ahead of print]

PMID:
29897009
3.

Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project.

de Wilde A, van der Flier WM, Pelkmans W, Bouwman F, Verwer J, Groot C, van Buchem MM, Zwan M, Ossenkoppele R, Yaqub M, Kunneman M, Smets EMA, Barkhof F, Lammertsma AA, Stephens A, van Lier E, Biessels GJ, van Berckel BN, Scheltens P.

JAMA Neurol. 2018 Jun 11. doi: 10.1001/jamaneurol.2018.1346. [Epub ahead of print]

PMID:
29889941
4.

Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: single-agent effects of alkaline phosphatase and synergistic effects in combination with methotrexate.

Chandrupatla DMSH, Molthoff CFM, Ritsema WIGR, Vos R, Elshof E, Matsuyama T, Low PS, Musters RJP, Hammond A, Windhorst AD, Lammertsma AA, van der Laken CJ, Brands R, Jansen G.

Transl Res. 2018 May 17. pii: S1931-5244(18)30055-0. doi: 10.1016/j.trsl.2018.04.001. [Epub ahead of print]

5.

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model.

van der Wildt B, Wilhelmus MMM, Beaino W, Kooijman EJM, Schuit RC, Bol JGJM, Breve JJP, Pasternack R, Lammertsma AA, Windhorst AD, Drukarch B.

EJNMMI Res. 2018 May 25;8(1):39. doi: 10.1186/s13550-018-0388-2.

6.

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.

Jauw YWS, Heijtel DF, Zijlstra JM, Hoekstra OS, de Vet HCW, Vugts DJ, Verheul HM, Boellaard R, Zweegman S, van Dongen GAMS, der Houven van Oordt CWM, Lammertsma AA, Huisman MC.

Mol Imaging Biol. 2018 Apr 30. doi: 10.1007/s11307-018-1200-4. [Epub ahead of print]

PMID:
29713958
7.

Impact of Revascularization on Absolute Myocardial Blood Flow as Assessed by Serial [15O]H2O Positron Emission Tomography Imaging: A Comparison With Fractional Flow Reserve.

Driessen RS, Danad I, Stuijfzand WJ, Schumacher SP, Knuuti J, Mäki M, Lammertsma AA, van Rossum AC, van Royen N, Raijmakers PG, Knaapen P.

Circ Cardiovasc Imaging. 2018 May;11(5):e007417. doi: 10.1161/CIRCIMAGING.117.007417.

PMID:
29703779
8.

Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation.

Janssen B, Vugts DJ, Wilkinson SM, Ory D, Chalon S, Hoozemans JJM, Schuit RC, Beaino W, Kooijman EJM, van den Hoek J, Chishty M, Doméné A, Van der Perren A, Villa A, Maggi A, Molenaar GT, Funke U, Shevchenko RV, Baekelandt V, Bormans G, Lammertsma AA, Kassiou M, Windhorst AD.

Sci Rep. 2018 Apr 26;8(1):6580. doi: 10.1038/s41598-018-24814-0.

9.

Imaging and Methotrexate Response Monitoring of Systemic Inflammation in Arthritic Rats Employing the Macrophage PET Tracer [18F]Fluoro-PEG-Folate.

Chandrupatla DMSH, Jansen G, Mantel E, Low PS, Matsuyama T, Musters RP, Windhorst AD, Lammertsma AA, Molthoff CFM, van der Laken CJ.

Contrast Media Mol Imaging. 2018 Feb 21;2018:8092781. doi: 10.1155/2018/8092781. eCollection 2018.

10.

Reproducibility and repeatability of semi-quantitative 18F-fluorodihydrotestosterone (FDHT) uptake metrics in castration-resistant prostate cancer metastases: a prospective multi-center study.

Vargas HA, Kramer GM, Scott AM, Weickhardt A, Meier AA, Parada N, Beattie BJ, Humm JL, Staton KD, Zanzonico PB, Lyashchenko SK, Lewis JS, Yaqub M, Sosa RE, van den Eertwegh AJ, Davis ID, Ackermann U, Pathmaraj K, Schuit RC, Windhorst AD, Chua S, Weber WA, Larson SM, Scher HI, Lammertsma AA, Hoekstra O, Morris MJ.

J Nucl Med. 2018 Apr 6. pii: jnumed.117.206490. doi: 10.2967/jnumed.117.206490. [Epub ahead of print]

PMID:
29626121
11.

Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography.

Timmers T, van Berckel BNM, Lammertsma AA, Ossenkoppele R.

Methods Mol Biol. 2018;1750:221-229. doi: 10.1007/978-1-4939-7704-8_15.

PMID:
29512076
12.

Automated SPECT analysis compared with expert visual scoring for the detection of FFR-defined coronary artery disease.

Driessen RS, Raijmakers PG, Danad I, Stuijfzand WJ, Schumacher SP, Leipsic JA, Min JK, Knuuti J, Lammertsma AA, van Rossum AC, van Royen N, Underwood SR, Knaapen P.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1091-1100. doi: 10.1007/s00259-018-3951-1. Epub 2018 Feb 22.

13.

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography.

Bruijnen STG, Verweij NJF, van Duivenvoorde LM, Bravenboer N, Baeten DLP, van Denderen CJ, van der Horst-Bruinsma IE, Voskuyl AE, Custers M, van de Ven PM, Bot JCJ, Boden BJH, Lammertsma AA, Hoekstra OSH, Raijmakers PGHM, van der Laken CJ.

Rheumatology (Oxford). 2018 Apr 1;57(4):770. doi: 10.1093/rheumatology/key034. No abstract available.

14.

Effect of Plaque Burden and Morphology on Myocardial Blood Flow and Fractional Flow Reserve.

Driessen RS, Stuijfzand WJ, Raijmakers PG, Danad I, Min JK, Leipsic JA, Ahmadi A, Narula J, van de Ven PM, Huisman MC, Lammertsma AA, van Rossum AC, van Royen N, Knaapen P.

J Am Coll Cardiol. 2018 Feb 6;71(5):499-509. doi: 10.1016/j.jacc.2017.11.054.

PMID:
29406855
15.

Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.

Jauw YWS, Huisman MC, Nayak TK, Vugts DJ, Christen R, Naegelen VM, Ruettinger D, Heil F, Lammertsma AA, Verheul HMW, Hoekstra OS, van Dongen GAMS, Menke-van der Houven van Oordt CW.

EJNMMI Res. 2018 Jan 22;8(1):6. doi: 10.1186/s13550-018-0358-8.

16.

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography.

Bruijnen STG, Verweij NJF, van Duivenvoorde LM, Bravenboer N, Baeten DLP, van Denderen CJ, van der Horst-Bruinsma IE, Voskuyl AE, Custers M, van de Ven PM, Bot JCJ, Boden BJH, Lammertsma AA, Hoekstra OSH, Raijmakers PGHM, van der Laken CJ.

Rheumatology (Oxford). 2018 Apr 1;57(4):631-638. doi: 10.1093/rheumatology/kex448. Erratum in: Rheumatology (Oxford). 2018 Apr 1;57(4):770.

17.

Diagnostic Value of Transluminal Attenuation Gradient for the Presence of Ischemia as Defined by Fractional Flow Reserve and Quantitative Positron Emission Tomography.

Bom MJ, Driessen RS, Stuijfzand WJ, Raijmakers PG, Van Kuijk CC, Lammertsma AA, van Rossum AC, van Royen N, Knuuti J, Mäki M, Nieman K, Min JK, Leipsic JA, Danad I, Knaapen P.

JACC Cardiovasc Imaging. 2017 Dec 8. pii: S1936-878X(17)30990-7. doi: 10.1016/j.jcmg.2017.10.009. [Epub ahead of print]

PMID:
29248645
18.

Model selection criteria for dynamic brain PET studies.

Golla SSV, Adriaanse SM, Yaqub M, Windhorst AD, Lammertsma AA, van Berckel BNM, Boellaard R.

EJNMMI Phys. 2017 Dec 6;4(1):30. doi: 10.1186/s40658-017-0197-0.

19.

Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood-Brain Barrier Using Elacridar and 11C-Erlotinib PET.

Verheijen RB, Yaqub M, Sawicki E, van Tellingen O, Lammertsma AA, Nuijen B, Schellens JHM, Beijnen JH, Huitema ADR, Hendrikse NH, Steeghs N.

J Nucl Med. 2018 Jun;59(6):973-979. doi: 10.2967/jnumed.117.195800. Epub 2017 Nov 24.

PMID:
29175983
20.

Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET Imaging.

Raaphorst RM, Savolainen H, Cantore M, van de Steeg E, van Waarde A, Colabufo NA, Elsinga PH, Lammertsma AA, Windhorst AD, Luurtsema G.

Pharmaceuticals (Basel). 2017 Sep 20;10(3). pii: E76. doi: 10.3390/ph10030076.

21.

Semi-quantitative cerebral blood flow parameters derived from non-invasive [15O]H2O PET studies.

Koopman T, Yaqub M, Heijtel DF, Nederveen AJ, van Berckel BN, Lammertsma AA, Boellaard R.

J Cereb Blood Flow Metab. 2017 Jan 1:271678X17730654. doi: 10.1177/0271678X17730654. [Epub ahead of print]

PMID:
28901822
22.

[18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva.

Eekhoff EMW, Botman E, Coen Netelenbos J, de Graaf P, Bravenboer N, Micha D, Pals G, de Vries TJ, Schoenmaker T, Hoebink M, Lammertsma AA, Raijmakers PGHM.

Bone. 2018 Apr;109:143-146. doi: 10.1016/j.bone.2017.08.012. Epub 2017 Aug 18.

PMID:
28826841
23.

Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve.

Danad I, Raijmakers PG, Driessen RS, Leipsic J, Raju R, Naoum C, Knuuti J, Mäki M, Underwood RS, Min JK, Elmore K, Stuijfzand WJ, van Royen N, Tulevski II, Somsen AG, Huisman MC, van Lingen AA, Heymans MW, van de Ven PM, van Kuijk C, Lammertsma AA, van Rossum AC, Knaapen P.

JAMA Cardiol. 2017 Oct 1;2(10):1100-1107. doi: 10.1001/jamacardio.2017.2471.

PMID:
28813561
24.

Radiosynthesis of 1-iodo-2-[11 C]methylpropane and 2-methyl-1-[11 C]propanol and its application for alkylation reactions and C-C bond formation.

Rotteveel L, Poot AJ, Funke U, Pekošak A, Filp U, Lammertsma AA, Windhorst AD.

J Labelled Comp Radiopharm. 2017 Oct;60(12):566-576. doi: 10.1002/jlcr.3536. Epub 2017 Sep 26.

PMID:
28755455
25.

Synthesis and Evaluation of New Fluorine-18 Labeled Verapamil Analogs To Investigate the Function of P-Glycoprotein in the Blood-Brain Barrier.

Raaphorst RM, Luurtsema G, Schuit RC, Kooijman EJM, Elsinga PH, Lammertsma AA, Windhorst AD.

ACS Chem Neurosci. 2017 Sep 20;8(9):1925-1936. doi: 10.1021/acschemneuro.7b00086. Epub 2017 Jul 10.

26.

In-vivo monitoring of anti-folate therapy in arthritic rats using [18F]fluoro-PEG-folate and positron emission tomography.

Chandrupatla DMSH, Jansen G, Vos R, Verlaan M, Chen Q, Low PS, Windhorst AD, Lammertsma AA, van der Laken CJ, Molthoff CFM.

Arthritis Res Ther. 2017 May 31;19(1):114. doi: 10.1186/s13075-017-1325-x.

27.

Synthesis, radiolabeling and preclinical evaluation of a [11C]GMOM derivative as PET radiotracer for the ion channel of the N-methyl-D-aspartate receptor.

Klein PJ, Schuit RC, Metaxas A, Christiaans JAM, Kooijman E, Lammertsma AA, van Berckel BNM, Windhorst AD.

Nucl Med Biol. 2017 Aug;51:25-32. doi: 10.1016/j.nucmedbio.2017.05.003. Epub 2017 May 8.

28.

Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.

Chen WJY, Diamant M, de Boer K, Harms HJ, Robbers LFHJ, van Rossum AC, Kramer MHH, Lammertsma AA, Knaapen P.

Cardiovasc Diabetol. 2017 May 19;16(1):67. doi: 10.1186/s12933-017-0549-z.

29.

Forward to the Past: The Case for Quantitative PET Imaging.

Lammertsma AA.

J Nucl Med. 2017 Jul;58(7):1019-1024. doi: 10.2967/jnumed.116.188029. Epub 2017 May 18. Review.

30.

Disease Stage-Dependent Changes in Cardiac Contractile Performance and Oxygen Utilization Underlie Reduced Myocardial Efficiency in Human Inherited Hypertrophic Cardiomyopathy.

Güçlü A, Knaapen P, Harms HJ, Parbhudayal RY, Michels M, Lammertsma AA, van Rossum AC, Germans T, van der Velden J.

Circ Cardiovasc Imaging. 2017 May;10(5). pii: e005604. doi: 10.1161/CIRCIMAGING.116.005604.

31.

Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study.

Hagens MH, Killestein J, Yaqub MM, van Dongen GA, Lammertsma AA, Barkhof F, van Berckel BN.

Mult Scler. 2018 Apr;24(4):543-545. doi: 10.1177/1352458517704507. Epub 2017 Apr 26.

32.

Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising.

Golla SSV, Lubberink M, van Berckel BNM, Lammertsma AA, Boellaard R.

EJNMMI Res. 2017 Dec;7(1):36. doi: 10.1186/s13550-017-0284-1. Epub 2017 Apr 21.

33.

Quantification of Tau Load Using [18F]AV1451 PET.

Golla SSV, Timmers T, Ossenkoppele R, Groot C, Verfaillie S, Scheltens P, van der Flier WM, Schwarte L, Mintun MA, Devous M, Schuit RC, Windhorst AD, Lammertsma AA, Boellaard R, van Berckel BNM, Yaqub M.

Mol Imaging Biol. 2017 Dec;19(6):963-971. doi: 10.1007/s11307-017-1080-z.

34.

Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function.

Stuijfzand WJ, Biesbroek PS, Raijmakers PG, Driessen RS, Schumacher SP, van Diemen P, van den Berg J, Nijveldt R, Lammertsma AA, Walsh SJ, Hanratty CG, Spratt JC, van Rossum AC, Nap A, van Royen N, Knaapen P.

EuroIntervention. 2017 Jun 20;13(3):345-354. doi: 10.4244/EIJ-D-16-01014.

35.

Human Dosimetry of the N-Methyl-d-Aspartate Receptor Ligand 11C-GMOM.

van der Aart J, van der Doef TF, Horstman P, Huisman MC, Schuit RC, van Lingen A, Windhorst AD, van Berckel BNM, Lammertsma AA.

J Nucl Med. 2017 Aug;58(8):1330-1333. doi: 10.2967/jnumed.116.188250. Epub 2017 Feb 9.

PMID:
28183990
36.

A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor.

Petrulli JR, Hansen SB, Abourbeh G, Yaqub M, Bahce I, Holden D, Huang Y, Nabulsi NB, Contessa JN, Mishani E, Lammertsma AA, Morris ED.

Nucl Med Biol. 2017 Apr;47:56-61. doi: 10.1016/j.nucmedbio.2016.12.009. Epub 2017 Jan 2.

37.

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia.

Zwan MD, Bouwman FH, Konijnenberg E, van der Flier WM, Lammertsma AA, Verhey FR, Aalten P, van Berckel BN, Scheltens P.

Alzheimers Res Ther. 2017 Jan 17;9(1):2. doi: 10.1186/s13195-016-0228-4.

38.

Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis.

Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):559-560. doi: 10.1007/s00259-016-3598-8. No abstract available.

PMID:
27987029
39.

The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis.

Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):353-357. doi: 10.1007/s00259-016-3589-9. Epub 2016 Dec 6. No abstract available. Erratum in: Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):559-560. Saraf LJ [corrected to Jafari L].

PMID:
27924371
40.

Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase.

van der Wildt B, Wilhelmus MM, Kooijman EJ, Jongenelen CA, Schuit RC, Büchold C, Pasternack R, Lammertsma AA, Drukarch B, Windhorst AD.

Nucl Med Biol. 2017 Jan;44:90-104. doi: 10.1016/j.nucmedbio.2016.10.002. Epub 2016 Oct 18.

PMID:
27837727
41.

Parametric Methods for Dynamic 11C-Phenytoin PET Studies.

Mansor S, Yaqub M, Boellaard R, Froklage FE, de Vries A, Bakker ED, Voskuyl RA, Eriksson J, Schwarte LA, Verbeek J, Windhorst AD, Lammertsma AA.

J Nucl Med. 2017 Mar;58(3):479-483. doi: 10.2967/jnumed.116.178707. Epub 2016 Sep 22.

42.

In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis.

van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R, de Haan L, Eriksson J, Lammertsma AA, Kahn RS, van Berckel BN.

NPJ Schizophr. 2016 Aug 31;2:16031. doi: 10.1038/npjschz.2016.31. eCollection 2016.

43.

Prevalence of ischaemia in patients with a chronic total occlusion and preserved left ventricular ejection fraction.

Stuijfzand WJ, Driessen RS, Raijmakers PG, Rijnierse MT, Maeremans J, Hollander MR, Lammertsma AA, van Rossum AC, Dens J, Nap A, van Royen N, Knaapen P.

Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1025-1033. doi: 10.1093/ehjci/jew188.

PMID:
27585716
44.

Guidelines to PET measurements of the target occupancy in the brain for drug development.

Takano A, Varrone A, Gulyás B, Salvadori P, Gee A, Windhorst A, Vercouillie J, Bormans G, Lammertsma AA, Halldin C.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2255-2262. Epub 2016 Aug 11.

45.

Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial.

Stuijfzand WJ, Raijmakers PG, Driessen RS, Lammertsma AA, van Rossum AC, Nap A, Appelman Y, Lemkes JS, van Leeuwen MA, van Royen N, Knaapen P.

EuroIntervention. 2016 Aug 5;12(5):e584-94. doi: 10.4244/EIJV12I5A98.

46.

An automatic delineation method for bone marrow absorbed dose estimation in (89)Zr PET/CT studies.

Makris NE, Boellaard R, Menke CW, Lammertsma AA, Huisman MC.

EJNMMI Phys. 2016 Dec;3(1):13. doi: 10.1186/s40658-016-0149-0. Epub 2016 Jul 22.

47.

Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.

van der Wildt B, Lammertsma AA, Drukarch B, Windhorst AD.

Amino Acids. 2017 Mar;49(3):585-595. doi: 10.1007/s00726-016-2288-y. Epub 2016 Jul 5. Review.

48.

Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET.

Bahce I, Yaqub M, Smit EF, Lammertsma AA, van Dongen GA, Hendrikse NH.

Lung Cancer. 2017 May;107:1-13. doi: 10.1016/j.lungcan.2016.05.025. Epub 2016 May 31. Review.

49.

Parametric Binding Images of the TSPO Ligand 18F-DPA-714.

Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Te Beek ET, Groeneveld GJ, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne JO.

J Nucl Med. 2016 Oct;57(10):1543-1547. Epub 2016 Jun 3.

50.

Noninvasive Quantification of Myocardial 11C-Meta-Hydroxyephedrine Kinetics.

Harms HJ, Huisman MC, Rijnierse MT, Greuter H, Hsieh YL, de Haan S, Schuit RC, Knaapen P, Lubberink M, Lammertsma AA.

J Nucl Med. 2016 Sep;57(9):1376-81. doi: 10.2967/jnumed.115.167437. Epub 2016 May 26.

Supplemental Content

Loading ...
Support Center